Cargando…
A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial [Retraction]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015672/ https://www.ncbi.nlm.nih.gov/pubmed/35444453 http://dx.doi.org/10.2147/JIR.S369945 |
Ejemplares similares
-
A Potential Role of Ethosuximide and Pentoxifylline in Relieving Abdominal Pain in Irritable Bowel Syndrome Patients Treated with Mebeverine: A Randomized, Double-Blind, Placebo-Controlled Trial
por: El-Haggar, Sahar M, et al.
Publicado: (2022) -
Will controlled release mebeverine be able to surpass placebo in treatment of diarrhoea predominant irritable bowel syndrome?
por: Chakraborty, Dwaipayan Sarathi, et al.
Publicado: (2019) -
Assessment of the effectiveness and safety of ethosuximide in the treatment of abdominal pain related to irritable bowel syndrome – IBSET: protocol of a randomised, parallel, controlled, double-blind and multicentre trial
por: Kerckhove, Nicolas, et al.
Publicado: (2017) -
Mebeverine for Pediatric Functional Abdominal Pain: A Randomized, Placebo-Controlled Trial
por: Pourmoghaddas, Zahra, et al.
Publicado: (2014) -
The Efficacy of Mebeverine in the Treatment of Irritable Bowel Syndrome—A Systematic Review
por: Daniluk, Jaroslaw, et al.
Publicado: (2022)